Literature DB >> 22495358

Delay to formalin fixation alters morphology and immunohistochemistry for breast carcinoma.

Thaer Khoury1.   

Abstract

BACKGROUND: Delay to formalin fixation (DFF) also known as cold ischemia has been known to have an adverse effect on breast biomarkers. The aim of the study was to further evaluate the effect of DFF on tumor histomorphology and immunohistochemistry.
MATERIALS AND METHODS: Ten palpable invasive breast carcinomas were resected and underwent immediate gross evaluation. For each case, the procured tumor was divided into 8 equal parts and consecutively fixed after 0, 10, and 30 minutes, 1, 2, 4, and 8 hours; 1 section was kept in saline and stored overnight at 4°C. Stains normally used in breast pathology including epidermal growth factor receptor, Ki-67, p53, AE 1/3, CAM-5.2, cytokeratin (CK)7, CK14, CK5/6, epithelial membrane antigen, E-cadherin, gross cystic disease fluid protein 15, and mammaglobin were studied. The change was considered significant if it had any pathologic or clinical consequence.
RESULTS: DFF had spurious effect on 9 of 10 cases. However, significant alteration that affected the histomorphologic interpretation was observed in 3 cases. Significant immunohistochemistry alteration was seen only in the membranous markers (epidermal growth factor receptor and E-cadherin). Although the quality of the cytoplasmic markers was affected, the interpretation (positive vs. negative) was not affected by DFF. Ki-67 had minimal but insignificant change. Generally, these changes occurred at or after 2-hour mark.
CONCLUSIONS: Therefore, specimens should be fixed within 1 hour from tissue harvesting and not stored without fixation overnight.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495358     DOI: 10.1097/PAI.0b013e318248bf6d

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  9 in total

Review 1.  Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.

Authors:  Ludmila Prudkin; Paolo Nuciforo
Journal:  Cell Oncol (Dordr)       Date:  2014-09-04       Impact factor: 6.730

Review 2.  Effects of Cold Ischemia on Gene Expression: A Review and Commentary.

Authors:  William E Grizzle; Dennis Otali; Katherine C Sexton; Daniel S Atherton
Journal:  Biopreserv Biobank       Date:  2016-08-23       Impact factor: 2.300

3.  The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand.

Authors:  Supinda Koonmee; Sakkarn Sangkhamanon; Piyapharom Intarawichian; Chaiwat Aphivatanasiri; Waritta Kunprom; Prakasit Sa-Ngiamwibool; Suwit Balthaisong; Chitsakul Phuyao; Piya Prajumwongs; Reza Alaghehbandan; Malinee Thanee
Journal:  Front Public Health       Date:  2022-06-10

4.  Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using Immunohistochemistry.

Authors:  Aditi Bagchi; Zachary Madaj; Kelly B Engel; Ping Guan; Daniel C Rohrer; Dana R Valley; Emily Wolfrum; Kristin Feenstra; Nancy Roche; Galen Hostetter; Helen M Moore; Scott D Jewell
Journal:  J Histochem Cytochem       Date:  2021-03-01       Impact factor: 2.479

5.  Storage Conditions and Immunoreactivity of Breast Cancer Subtyping Markers in Tissue Microarray Sections.

Authors:  Angela R Omilian; Gary R Zirpoli; Ting-Yuan David Cheng; Song Yao; Leighton Stein; Warren Davis; Karen L Head; Priya Nair; Thaer Khoury; Christine B Ambrosone; Wiam Bshara
Journal:  Appl Immunohistochem Mol Morphol       Date:  2020-04

Review 6.  Quantification of HER family receptors in breast cancer.

Authors:  Paolo Nuciforo; Nina Radosevic-Robin; Tony Ng; Maurizio Scaltriti
Journal:  Breast Cancer Res       Date:  2015-04-09       Impact factor: 6.466

Review 7.  Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists.

Authors:  Carlos Parra-Herran; Anais Malpica; Esther Oliva; Gian Franco Zannoni; Pedro T Ramirez; Joseph T Rabban
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

8.  Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.

Authors:  Thaer Khoury; Gary Zirpoli; Stephanie M Cohen; Joseph Geradts; Angela Omilian; Warren Davis; Wiam Bshara; Ryan Miller; Michelle M Mathews; Melissa Troester; Julie R Palmer; Christine B Ambrosone
Journal:  Am J Clin Pathol       Date:  2017-08-01       Impact factor: 2.493

Review 9.  Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Authors:  Suzanne A Eccles; Eric O Aboagye; Simak Ali; Annie S Anderson; Jo Armes; Fedor Berditchevski; Jeremy P Blaydes; Keith Brennan; Nicola J Brown; Helen E Bryant; Nigel J Bundred; Joy M Burchell; Anna M Campbell; Jason S Carroll; Robert B Clarke; Charlotte E Coles; Gary J R Cook; Angela Cox; Nicola J Curtin; Lodewijk V Dekker; Isabel dos Santos Silva; Stephen W Duffy; Douglas F Easton; Diana M Eccles; Dylan R Edwards; Joanne Edwards; D Evans; Deborah F Fenlon; James M Flanagan; Claire Foster; William M Gallagher; Montserrat Garcia-Closas; Julia M W Gee; Andy J Gescher; Vicky Goh; Ashley M Groves; Amanda J Harvey; Michelle Harvie; Bryan T Hennessy; Stephen Hiscox; Ingunn Holen; Sacha J Howell; Anthony Howell; Gill Hubbard; Nick Hulbert-Williams; Myra S Hunter; Bharat Jasani; Louise J Jones; Timothy J Key; Cliona C Kirwan; Anthony Kong; Ian H Kunkler; Simon P Langdon; Martin O Leach; David J Mann; John F Marshall; Lesley Martin; Stewart G Martin; Jennifer E Macdougall; David W Miles; William R Miller; Joanna R Morris; Sue M Moss; Paul Mullan; Rachel Natrajan; James P B O'Connor; Rosemary O'Connor; Carlo Palmieri; Paul D P Pharoah; Emad A Rakha; Elizabeth Reed; Simon P Robinson; Erik Sahai; John M Saxton; Peter Schmid; Matthew J Smalley; Valerie Speirs; Robert Stein; John Stingl; Charles H Streuli; Andrew N J Tutt; Galina Velikova; Rosemary A Walker; Christine J Watson; Kaye J Williams; Leonie S Young; Alastair M Thompson
Journal:  Breast Cancer Res       Date:  2013-10-01       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.